ロード中...
Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
BACKGROUND: TP53 mutation is the most common mutation in hepatocellular carcinoma (HCC), and it affects the progression and prognosis of HCC. We investigated how TP53 mutation regulates the HCC immunophenotype and thus affects the prognosis of HCC. METHODS: We investigated TP53 mutation status and R...
保存先:
| 出版年: | EBioMedicine |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491941/ https://ncbi.nlm.nih.gov/pubmed/30885723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.03.022 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|